Correlation Procalcitonin (PCT) to Neutrophil Lymphocyte Ratio (NLR) in Covid-19 Patient

Authors

  • Isnawati Apriliani Department of Medical Laboratory Technology, Health Polytechnique of Jakarta III Jakarta Indonesia, Indonesia
  • Rizana Fajrunni’mah Department of Medical Laboratory Technology, Health Polytechnique of Jakarta III Jakarta Indonesia, Indonesia
  • Husjain Djajaningrat Department of Medical Laboratory Technology, Health Polytechnique of Jakarta III Jakarta Indonesia, Indonesia
  • Aninda Dinar Widiantari Research Installation, Sulianti Saroso Infectious Disease Hospital Jakarta, Indonesia, Indonesia
  • Farida Murtiani Research Installation, Sulianti Saroso Infectious Disease Hospital Jakarta, Indonesia, Indonesia https://orcid.org/0000-0003-4992-117X

DOI:

https://doi.org/10.36408/mhjcm.v10i1.855

Keywords:

COVID-19, Procalcitonin (PCT), Neutrophil Lymphocyte Ratio (NLR)

Abstract

BACKGROUND: Covid-19 treatment should be done early before the disease progress. Inflammatory biomarker is needed to ascertain the severity of disease as soon as possible.  Neutrophil-to-lymphocyte ratio (NLR) and Procalcitonin (PCT) are two of biomarker that are clinically used around the world. NLR is simpler, can routinely be done and available in peripheral region while PCT is more effective to describe inflammation.

PURPOSE: This study aims to determine the correlation of procalcitonin (PCT) levels with neutrophil lymphocyte ratio (NLR) in COVID-19 patients.

METHOD: This study is an analytic observational with a cross sectional design. We extracted data from medical record. Samples were 415 COVID-19 patients undergoing inpatient care at the Budhi Asih Hospital, East Jakarta for January - December 2021.

RESULTS: Prevalence of male patients more than ≥60 years were 78 patients (18,8%) while female patients were 68 patients (16,4%). Average of PCT level was 1,93 ng/mL (0,02-200 ng/mL). Average of NLR was 5,09 cells/mm3 (0,22-31 cells/mm3). Spearman test proved there was a significant correlation between PCT and NLR levels in COVID-19 patients (p value = 0,0001).

CONCLUSION: The higher the PCT level, the higher the NLR value in COVID-19 patients.

Downloads

Download data is not yet available.

References

  1. Kementerian Kesehatan. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Jakarta; 2020 Mar.
  2. Khaerunnisa R, Rumana NA, Yulia N, Fannya P. Gambaran Karakteristik Pasien Covid-19 di Rumah Sakit Mekar Sari Bekasi Tahun 2020-2021. Jurnal Manajemen Informasi Kesehatan Indonesia. 2022 Mar 2;10(1):72.
  3. Klinik MP, Pengelola S, Ilmiah J, Klinik Indonesia P. Indonesian Journal of Clinical Pathology And Medical Laboratory. 2013;19(2).
  4. Rosyanti L, Hadi I. The Immunity Response and Severe Acute Respiratory Syndrome Coronavirus-2 Cytokine Storm Literature Review. Jurnal Kesehatan Madani Medika [Internet]. 2020 Dec;11(02):176–201. Available from: https://covid19.go.id/
  5. Paramythiotis D, Digkas E, Dryllis G. 5 Biomarkers and Physiological Agents in Severe Sepsis and Septic Shock [Internet]. Thessaloniki; 2012. Available from: www.intechopen.com
  6. Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, et al. The Relation between Atherosclerosis and the Neutrophil-Lymphocyte Ratio. Clinical and Applied Thrombosis/Hemostasis. 2016 Jul 1;22(5):405–11.
  7. Song Y, Sun W, Dai D, Liu Y, Li Z, Tian Z, et al. Prediction value of procalcitonin combining CURB-65 for 90-day mortality in community-acquired pneumonia. Expert Rev Respir Med. 2021;15(5):689–96.
  8. Ocakli B, Tuncay E, Gungor S, Sertbas M, Adiguzel N, Irmak I, et al. Inflammatory Markers in Patients Using Domiciliary Non-invasive Mechanical Ventilation: C Reactive Protein, Procalcitonin, Neutrophil Lymphocyte Ratio. Front Public Health. 2018 Sep 5;6.
  9. Sarvasti D. Pengaruh Gender dan Manifestasi Kardiovaskular Pada COVID-19. Indonesian Journal of Cardiology. 2020 Jun 1;
  10. Xu J bo, Xu C, Zhang R bing, Wu M, Pan C kun, Li X jie, et al. Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China. Sci Rep. 2020 Dec 1;10(1).
  11. Gregoriano C, Koch D, Haubitz S, Conen A, Fux CA, Mueller B, et al. Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: An observational analysis. Swiss Med Wkly. 2020 Jul 15;150(29–30).
  12. Khaerunnisa R, Rumana NA, Yulia N, Fannya P. Gambaran Karakteristik Pasien Covid-19 di Rumah Sakit Mekar Sari Bekasi Tahun 2020-2021. Jurnal Manajemen Informasi Kesehatan Indonesia [Internet]. 2022 Mar 2;10(1):72. Available from: https://jmiki.aptirmik.or.id/index.php/jmiki/article/view/64
  13. Purwitasari M, Burhan E, Soepandi PZ. Peranan Prokalsitonin pada Pneumonnia Komunitas. The Indonesian Journal of Infectious Disease. 2017;37–41.
  14. Puspitasari AA, Evi R, Dira N. Korelasi Antara Profil Hematologi Dengan Procalcitonin Pada Pasien Terkonfirmasi Covid-19. Vol. 1, Surabaya : The Journal of Muhamadiyah Medical Laboratory Technologist. 2021.
  15. Arif SK, Rukka ABS, Wahyuni S. Comparison of neutrophils-lymphocytes ratio and procalcitonin parameters in sepsis patient treated in intensive care unit Dr. Wahidin hospital, Makassar, Indonesia. Journal of Medical Sciences. 2017;17(1):17–21.
  16. Lestari DP. Perbandingan Neutrophil Lymphocyte Ratio (NLR) pada Wanita Hamil dan Tidak Hamil dengan Diagnosis COVID19 di RS Universitas Mataram. Lombok Medical Journal. 2022;1(1):44–8.
  17. Permana A, Nugroho HP, Dewi RK. Gambaran Netrofil pada Pasien Covid-19 di Rumah Sakit Siloam Bogor. Jurnal Ilmiah Analis Kesehatan [Internet]. 2021;7(2). Available from: http://journal.thamrin.ac.id/index.php/anakes/issue/view/52
  18. Damar Çakırca T, Torun A, Çakırca G, Portakal RD. Role of NLR, PLR, ELR and CLR in differentiating COVID-19 patients with and without pneumonia. Int J Clin Pract. 2021 Nov 1;75(11).
  19. Sayah W, Berkane I, Guermache I, Sabri M, Lakhal FZ, Yasmine Rahali S, et al. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Cytokine. 2021 May 1;141.
  20. Feng X, Li S, Sun Q, Zhu J, Chen B, Xiong M, et al. Immune-inflammatory parameters in COVID-19 cases: A systematic review and meta-analysis. Vol. 7, Frontiers in Medicine. Frontiers Media S.A.; 2020. p. 1–14.
  21. Keski H. Hematological and Inflammatory Parameters to Predict the Prognosis in COVID-19. Indian Journal of Hematology and Blood Transfusion [Internet]. 2021 Oct 1 [cited 2022 Nov 25];37(4):534–42. Available from: https://link.springer.com/article/10.1007/s12288-021-01407-y
  22. Wang K, Wang X, Du J, Liu C, Jiang Y, Zhang H, et al. Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe versus mild/moderate disease. Epidemiol Infect. 2021;1–12.

 

Additional Files

Published

2023-03-31

How to Cite

1.
Apriliani I, Fajrunni’mah R, Djajaningrat H, Widiantari AD, Murtiani F. Correlation Procalcitonin (PCT) to Neutrophil Lymphocyte Ratio (NLR) in Covid-19 Patient. Medica Hospitalia J. Clin. Med. [Internet]. 2023 Mar. 31 [cited 2024 May 3];10(1):98-101. Available from: http://medicahospitalia.rskariadi.co.id/medicahospitalia/index.php/mh/article/view/855

Issue

Vol. 10 No. 1 (2023): Med Hosp; March 2023

Section

Original Article

Citation Check

License

Copyright (c) 2023 Farida Murtiani, Isnawati Apriliani, Rizana Fajrunni’mah, Husjain Djajaningrat, Aninda Dinar Widiantari

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.